FrancophonIA/ELRC3.0 huggingface dataset:
English: It is thought that these symptoms are due to an improvement in the body's immune response, enabling the body to fight infections that may have been present with no obvious symptoms.
Slovenian: Prevladuje mnenje, da ti simptomi nastanejo zaradi izboljšanja imunskega odziva telesa, ki telesu omogoča, da se bori proti okužbam, ki so lahko prisotne brez očitnih simptomov.
English: depression, abnormal dreams
Slovenian: depresija, nenavadne sanje
English: In order to avoid transmission of HIV to the infant it is recommended that HIV-infected women do not breast-feed their infants under any circumstances.
Slovenian: Za preprečitev prenosa HIV na dojenčka se priporoča, da s HIV okužene ženske v nobenem primeru ne dojijo.
English: For more details, see section 3, Do not stop taking Biktarvy.
Slovenian: Za več podrobnosti glejte poglavje 3, Ne prenehajte jemati zdravila Biktarvy.
English: Ελλάδα Gilead Sciences Ελλάς Μ.ΕΠΕ.
Slovenian: Gilead Sciences Ελλάς Μ.ΕΠΕ.
English: This is because some of the active substances in this medicine pass into human breast milk.
Slovenian: To je zato, ker nekatere učinkovine tega zdravila prehajajo v materino mleko.
English: A dose adjustment of metformin should be considered if required.
Slovenian: Po potrebi je treba razmisliti o prilagoditvi odmerka metformina.
English: Emtricitabine can be removed by hemodialysis, which removes approximately 30% of the emtricitabine dose over a 3-hour dialysis period starting within 1.5 hours of emtricitabine dosing.
Slovenian: Emtricitabin se lahko odstrani s hemodializo, ki odstrani približno 30 % odmerka emtricitabina v 3 urah dialize, ki se začne v 1,5 ure od odmerjanja emtricitabina.
English: Patients must have been stably suppressed on their baseline regimen for at least 6 months and must not have been previously treated with any INSTI.
Slovenian: Bolniki so morali biti na izhodiščnem režimu vsaj 6 mesecev stabilno supresirani in niso smeli biti predhodno zdravljeni z nobenim INSTI.
English: Taking this type of medicine for a long time, taking corticosteroids, drinking alcohol, having a very weak immune system, and being overweight, may be some of the many risk factors for developing this disease.
Slovenian: Jemanje te vrste zdravil dolgo časa, jemanje kortikosteroidov, pitje alkohola, zelo šibek imunski sistem in prekomerna telesna masa so lahko nekateri od številnih dejavnikov tveganja za nastanek te bolezni.
English: Week 48
Slovenian: 48. tedna
English: Treatment of overdose with Biktarvy consists of general supportive measures including monitoring of vital signs as well as observation of the clinical status of the patient.
Slovenian: Zdravljenje prevelikega odmerka zdravila Biktarvy načeloma predstavljajo podporni ukrepi, vključno s spremljanjem vitalnih znakov in opazovanjem kliničnega stanja bolnika.
English: If you feel dizzy when taking Biktarvy, do not drive and do not use any tools or machines.
Slovenian: Če se vam med zdravljenjem z zdravilom Biktarvy pojavlja omotičnost, ne vozite avtomobila in ne upravljajte orodij ali strojev.
English: If you really want to breastfeed, talk to your doctor first.
Slovenian: Če resnično želite dojiti, se najprej posvetujte z zdravnikom.
English: 3 Study conducted with additional voxilaprevir 100 mg to achieve voxilaprevir exposures expected in HCV infected patients.
Slovenian: 3 Študija, izvedena z dodatnim voksilaprevirjem 100 mg za doseganje pričakovane izpostavljenosti voksilaprevirju pri bolnikih, okuženih z virusom HIV.
English: Tenofovir is efficiently removed by hemodialysis with an extraction coefficient of approximately 54%.
Slovenian: Tenofovir se učinkovito odstrani s hemodializo s koeficientom ekstrakcije približno 54 %.
English: The susceptibility of bictegravir was tested against 64 INSTI-resistant clinical isolates (20 with single substitutions and 44 with 2 or more substitutions).
Slovenian: Občutljivost biktegravirja so testirali za 64 kliničnih izolatov, rezistentnih na INSTI (20 z eno substitucijo in 44 z 2 ali več substitucijami).
English: • rifampicin used to treat some bacterial infections such as tuberculosis
Slovenian: • rifampicin - uporablja se za zdravljenje nekaterih bakterijskih okužb, kot je tuberkuloza
English: Treatment outcomes between treatment groups were similar across subgroups by age, sex, race, and region.
Slovenian: Izidi zdravljenja med skupinami zdravljenja so bili podobni v podskupinah glede na starost, spol, raso in regijo.
English: If you have hepatitis B infection, your doctor will carefully consider the best treatment regimen for you.
Slovenian: Če imate okužbo s hepatitisom B, bo zdravnik skrbno presodil režim zdravljenja, ki je za vas najprimernejši.
English: • If you have liver problems or a history of liver disease, including hepatitis.
Slovenian: • Če imate težave z jetri ali bolezen jeter v zdravstveni zgodovini, vključno s hepatitisom.
English: For more information see section 4, Possible side effects.
Slovenian: Za več informacij glejte poglavje 4, Možni neželeni učinki.
English: Biktarvy should be used during pregnancy only if the potential benefit justifies the potential risk to the foetus.
Slovenian: Zdravilo Biktarvy se sme med nosečnostjo uporabljati samo, če možne koristi upravičujejo možno tveganje za plod.
English: The EC50 values for emtricitabine were in the range of 0.0013 to 0.64 µM.
Slovenian: Vrednosti EC50 za emtricitabin so bile v razponu od 0,0013 do 0,64 µM.
English: Renal clearance of the unchanged parent was minimal.
Slovenian: Ledvični očistek nespremenjene izhodne spojine je bil minimalen.
English: • problems with digestion resulting in discomfort after meals (dyspepsia)
Slovenian: • prebavne motnje, ki privedejo do slabega počutja po zaužitem obroku (dispepsija)
English: Of those, 9 of the 14 isolates had additional mutations at L74M, T97A, or E138A/K.
Slovenian: Med temi je imelo 9 od 14 izolatov dodatne mutacije na L74M, T97A ali E138A/K.
English: This medicine is not a cure for HIV infection.
Slovenian: To zdravilo ne ozdravi okužbe z virusom HIV.
English: Pharmacotherapeutic group: Antiviral for systemic use; antivirals for treatment of HIV infections, combinations, ATC code: J05AR20
Slovenian: Farmakoterapevtska skupina: zdravilo za sistemsko zdravljenje virusnih infekcij, zdravila za zdravljenje infekcij s HIV, kombinacije, oznaka ATC: J05AR20
English: Do not use this medicine after the expiry date which is stated on the carton and bottle after {EXP}.
Slovenian: Tega zdravila ne smete uporabljati po datumu izteka roka uporabnosti, ki je naveden na škatli in plastenki poleg oznake {EXP}.
English: Other effects that may be seen during HIV treatment
Slovenian: Drugi možni učinki pri zdravljenju HIV
English: Possible side effects: tell a doctor immediately
Slovenian: Možni neželeni učinki: takoj obvestite svojega zdravnika
English: Medicines that must never be taken with Biktarvy:
Slovenian: Zdravila, ki jih ne smete nikoli uporabljati skupaj z zdravilom Biktarvy:
English: The plasma emtricitabine half-life was approximately 10 hours.
Slovenian: Razpolovni čas emtricitabina v plazmi je bil približno 10 ur.
English: As a result, the amounts of Biktarvy or other medicines in your blood may change.
Slovenian: To lahko posledično vpliva na količino zdravila Biktarvy ali drugih zdravil v vaši krvi.
English: It is also recommended that you do not breast-feed to avoid passing the virus to the baby in breast milk.
Slovenian: Poleg tega je priporočljivo, da ne dojite, tudi zato da s tem preprečite prenos virusa preko mleka na dojenčka.
English: A large amount of data on pregnant women (more than 1,000 exposed outcomes) indicate no malformative nor foetal/neonatal toxicity associated with emtricitabine.
Slovenian: Velika količina podatkov o nosečnicah (več kot 1.000 izidov izpostavljenih nosečnosti) pa ne kaže na malformacijsko ali feto/neonatalno toksičnost, povezano z emtricitabinom.
English: Do not use if seal over bottle opening is broken or missing.
Slovenian: Ne uporabljajte, če je folija čez odprtino plastenke poškodovana ali če manjka.
English: (Inhibition of OCT2/MATE1)
Slovenian: (zaviranje OCT2/MATE1)
English: EU/1/18/1289/001 30 film-coated tablets EU/1/18/1289/002 90 (3 bottles of 30) film-coated tablets
Slovenian: EU/1/18/1289/001 30 filmsko obloženih tablet EU/1/18/1289/002 90 (3 plastenke po 30) filmsko obloženih tablet
English: Biktarvy can be taken with or without food (see section 5.2).
Slovenian: Zdravilo Biktarvy se lahko jemlje s hrano ali brez nje (glejte poglavje 5.2).
English: In animal studies it has been shown that tenofovir is excreted in milk.
Slovenian: Študije na živalih so pokazale, da se tenofovir izloča v materino mleko.
English: In children whose mothers took nucleoside reverse transcriptase inhibitors (NRTIs) during pregnancy, the benefit from the protection against HIV outweighed the risk of side effects.
Slovenian: Pri otrocih, katerih matere so med nosečnostjo jemale nukleozidne zaviralce reverzne transkriptaze (NRTI), je korist zaščite pred virusom HIV odtehtala tveganje za neželene učinke.
English: • antibiotics used to treat bacterial infections, containing:
Slovenian: • antibiotike, ki se uporabljajo za zdravljenje bakterijskih okužb in vsebujejo:
English: If you have both HIV infection and hepatitis B, it is especially important not to stop your Biktarvy treatment without talking to your doctor first.
Slovenian: Če ste okuženi tako z virusom HIV kot s hepatitisom B, je še zlasti pomembno, da ne prenehate z zdravljenjem z zdravilom Biktarvy, ne da bi se prej posvetovali z zdravnikom.
English: • mineral supplements or vitamins containing magnesium or iron  See section 2 for more information on taking these medicines with Biktarvy.
Slovenian: • mineralne dodatke ali vitamine, ki vsebujejo magnezij ali železo  Glejte poglavje 2 za več informacij o jemanju teh zdravil skupaj z zdravilom Biktarvy.
English: Ex vivo binding of tenofovir alafenamide to human plasma proteins in samples collected during clinical studies was approximately 80%.
Slovenian: Ex vivo vezava alafenamidtenofovirata na humane plazemske proteine v vzorcih, odvzetih med kliničnimi študijami, je bila približno 80 %.
English: Therefore patients should remain under close clinical observation by physicians experienced in the treatment of patients with HIV associated diseases.
Slovenian: Bolnike mora zato natančno spremljati zdravnik z izkušnjami z zdravljenjem bolnikov z boleznimi, povezanimi s HIV.
English: Thirteen percent of the dose was recovered in the urine as three putative metabolites.
Slovenian: 13 % odmerka so izolirali v urinu kot tri domnevne presnovke.
English: Biktarvy reduces the amount of HIV in your body.
Slovenian: Zdravilo Biktarvy zmanjša količino virusa HIV v vašem telesu.
English: Bictegravir has been shown to increase serum creatinine due to inhibition of tubular secretion of creatinine, however these changes are not considered to be clinically relevant since they do not reflect a change in glomerular filtration rate.
Slovenian: Biktegravir dokazano zvišuje serumski kreatinin zaradi zaviranja tubularne sekrecije kreatinina, vendar te spremembe ne veljajo za klinično pomembne, saj ne spremenijo hitrosti glomerularne filtracije.
English: Patients with pre-existing liver dysfunction, including chronic active hepatitis, have an increased frequency of liver function abnormalities during combination antiretroviral therapy (CART) and should be monitored according to standard practice.
Slovenian: Bolniki z že obstoječo jetrno disfunkcijo, vključno s kroničnim aktivnim hepatitisom, imajo v času kombinirane protiretrovirusne terapije (CART - combination antiretroviral therapy) več anomalij jetrne funkcije in jih je treba nadzirati v skladu s standardno prakso.
English: Medicinal products that decrease renal function may increase concentrations of emtricitabine.
Slovenian: Zdravila, ki zmanjšajo delovanje ledvic, lahko zvišajo koncentracije emtricitabina.
English: The number of patients co-infected with HIV and HBV treated with B/F/TAF is limited.
Slovenian: Število bolnikov s sočasno okužbo s HIV in HBV, zdravljenih z B/F/TAF, je omejeno.
English: Ask your doctor or pharmacist for advice before taking any medicine when pregnant.
Slovenian: Posvetujte se z zdravnikom ali farmacevtom, preden vzamete katero koli zdravilo med nosečnostjo.
English: In vitro drug resistance selection studies with tenofovir alafenamide have shown no development of high-level resistance after extended culture.
Slovenian: In vitro študije selekcije rezistence na zdravilo z alafenamidtenofoviratom niso pokazale razvoja rezistence visoke stopnje po podaljšanju kulture.
English: This modest change is not considered clinically meaningful and B/F/TAF can be administered with or without food.
Slovenian: Ta skromna sprememba se ne smatra kot klinično pomembna, zato se lahko B/F/TAF daje s hrano ali brez nje.
English: Eighteen percent of patients had baseline viral loads greater than 100,000 copies/mL.
Slovenian: 18 % bolnikov je imelo izhodiščno virusno obremenitev več kot 100.000 kopij/ml.
English: • If you are allergic to bictegravir, emtricitabine, tenofovir alafenamide or any of the other ingredients of this medicine (listed in section 6).
Slovenian: • Če ste alergični na biktegravir, emtricitabin, alafenamidtenofovirat ali katero koli sestavino tega zdravila (navedeno v poglavju 6).
English: The safety and efficacy of Biktarvy in children under the age of 18 years have not yet been established.
Slovenian: Varnost in učinkovitost zdravila Biktarvy pri otrocih, mlajših od 18 let, še nista bili dokazani.
English: Table 1: Interactions between Biktarvy or its individual component(s) and other medicinal products
Slovenian: Preglednica 1: Interakcije med zdravilom Biktarvy ali posamičnimi sestavinami in drugimi zdravili
English: One patient had missing HBV DNA data at Week 48.
Slovenian: Podatki za enega bolnika za HBV DNA v 48. tednu so manjkali.
English: If you take more Biktarvy than you should
Slovenian: Če ste vzeli večji odmerek zdravila Biktarvy, kot bi smeli
English: • abnormal dreams
Slovenian: • nenavadne sanje
English: 5 Maximum strength antacid contained 80 mg aluminium hydroxide, 80 mg magnesium hydroxide, and 8 mg simethicone per mL.
Slovenian: 5 Antacid največje jakosti je vseboval 80 mg aluminijevega hidroksida, 80 mg magnezijevega hidroksida in 8 mg simetikona na ml.
English: The mean absolute bioavailability of emtricitabine from 200 mg hard capsules was 93%.
Slovenian: 200 mg trdih kapsul je bila 93 %.
English: The European Medicines Agency has deferred the obligation to submit the results of studies with Biktarvy in one or more subsets of the paediatric population in the treatment of human HIV-1 infection (see section 4.2 for information on paediatric use).
Slovenian: Evropska agencija za zdravila je začasno odložila zahtevo za predložitev rezultatov študij z zdravilom Biktarvy za eno ali več podskupin pediatrične populacije za zdravljenje okužbe z virusom HIV-1 pri ljudeh (za podatke o uporabi pri pediatrični populaciji glejte poglavje 4.2).
English: Biktarvy should not be taken simultaneously with supplements containing magnesium and/or aluminium due to the expected substantial decrease of bictegravir exposure (see section 4.4).
Slovenian: Zdravilo Biktarvy se ne sme jemati sočasno z dodatki , ki vsebujejo magnezij in/ali aluminij, zaradi pričakovanega bistvenega zmanjšanja izpostavljenosti biktegravirju (glejte poglavje 4.4).
English: In some patients with advanced liver disease or cirrhosis, stopping treatment is not recommended as this may lead to worsening of your hepatitis, which may be life-threatening.
Slovenian: Pri nekaterih bolnikih z napredovalim obolenjem jeter ali cirozo prenehanje zdravljenja ni priporočljivo, saj lahko to povzroči poslabšanje hepatitisa, ki je lahko življenjsko nevarno.
English: Following administration of [14C]-emtricitabine, complete recovery of the emtricitabine dose was achieved in urine (~86%) and faeces (~14%).
Slovenian: Po dajanju [14C] -emtricitabina so celotni odmerek emtricitabina izolirali iz urina (~ 86 %) in blata (~ 14 %).
English: Stopping Biktarvy can seriously affect how future treatment works.
Slovenian: Prenehanje jemanja zdravila Biktarvy lahko resno vpliva na to, kako bo zdravljenje v prihodnje delovalo.
English: 1 With the exception of angioedema, anaemia and urticaria (see footnotes 2, 3 and 4), all adverse reactions were identified from Biktarvy clinical studies.
Slovenian: 1 Razen angioedema, anemije in urtikarije (glejte opombe 2, 3 in 4) so vse neželene učinke opredelili v kliničnih študijah zdravila Biktarvy.
English: The plasma bictegravir half-life was 17.3 hours.
Slovenian: Razpolovni čas biktegravirja v plazmi je bil 17,3 ure.
English: In animal studies, bictegravir was detected in the plasma of nursing rat pups likely due to the presence of bictegravir in milk, without effects on nursing pups.
Slovenian: V študijah na živalih so biktegravir odkrili v plazmi dojenih podganjih mladičev, verjetno zaradi prisotnosti biktegravirja v mleku, brez učinka na dojene mladiče.
English: If you take more than the recommended dose of Biktarvy you may be at higher risk of side effects of this medicine (see section 4, Possible side effects).
Slovenian: Če ste zaužili odmerek zdravila Biktarvy, večji od priporočenega, obstaja povečano tveganje za pojav možnih neželenih učinkov (glejte poglavje 4, Možni neželeni učinki).
English: Mean percent change in AUC,
Slovenian: Povprečna sprememba AUC,
English: (11%) and Grade 2 (4%) (≥1.0 to 2.5 x Upper Limit of Normal [ULN]), and were not associated with hepatic adverse reactions or other liver related laboratory abnormalities.
Slovenian: Povečanja so bila pretežno 1. stopnje (11 %) in 2. stopnje (4 %) (≥ 1,0 do 2,5-kratnik zgornje meje normale [ULN - Upper Limit of Normal]) ter niso bila povezana z jetrnimi neželenimi učinki ali drugimi laboratorijskimi nenormalnostmi, povezanimi z jetri.
English: Mean systemic emtricitabine exposure was higher in patients with severe renal impairment (CrCl < 30 mL/min) (33.7 µg•h/mL) than in subjects with normal renal function (11.8 µg•h/mL).
Slovenian: Povprečna sistemska izpostavljenost emtricitabinu je bila večja pri bolnikih s hudo okvaro ledvic (CrCl < 30 ml/min) (33,7 µg•h/ml) kot pri preskušancih z normalnim delovanjem ledvic (11,8 µg•h/ml).
English: There is no specific antidote for overdose with Biktarvy.
Slovenian: Specifičnega antidota za preveliko odmerjanje zdravila Biktarvy ni.
English: The pharmacokinetics of emtricitabine have not been studied in subjects with hepatic impairment; however, emtricitabine is not significantly metabolised by liver enzymes, so the impact of liver impairment should be limited.
Slovenian: Farmakokinetičnih lastnosti emtricitabina pri bolnikih z jetrno okvaro niso proučevali, vendar jetrni encimi emtricitabina ne presnavljajo v pomembnem obsegu, zato je vpliv jetrne okvare verjetno omejen.
English: In some patients with advanced HIV infection (AIDS) and a history of opportunistic infections (infections that occur in people with a weak immune system), signs and symptoms of inflammation from previous infections may occur soon after HIV treatment is started.
Slovenian: Pri nekaterih bolnikih z napredovalo okužbo s HIV (AIDS) in oportunističnimi okužbami v zdravstveni zgodovini (okužbe, ki se pojavijo pri ljudeh z oslabljenim imunskim sistemom), se lahko kmalu po začetku zdravljenja HIV pojavijo znaki in simptomi vnetja zaradi prejšnjih okužb.
English:  If you notice these or any symptoms of inflammation or infection, tell your doctor immediately.
Slovenian:  Če opazite te simptome ali kakršne koli simptome vnetja ali okužbe, takoj obvestite zdravnika.
English: Hepatobiliary toxicity was described in a 39-week study at a dosage of 1,000 mg/kg/day, which resulted in exposures of approximately 16 times the exposure in humans at the recommended human dose, and was partially reversible after a 4-week recovery period.
Slovenian: Toksičnost za jetra, žolčnik in žolčevode je bila opisana v 39-tedenski študiji pri odmerku 1.000 mg/kg/dan, kar je povzročilo približno 16-kratno izpostavljenost v primerjavi z izpostavljenostjo pri ljudeh ob priporočenem odmerku, in je bila po 4-tedenskem obdobju okrevanja delno reverzibilna.
English: There are limited data on the use of Biktarvy in patients aged 65 years and over.
Slovenian: Podatki o uporabi zdravila Biktarvy pri bolnikih, starih 65 let in več, so omejeni.
English: A potential risk of nephrotoxicity resulting from chronic exposure to low levels of tenofovir due to dosing with tenofovir alafenamide cannot be excluded (see section 5.3).
Slovenian: Nefrotoksičnost Morebitnega tveganja nefrotoksičnosti kot posledice kronične izpostavljenosti nizkim ravnem tenofovirja zaradi odmerjanja alafenamidtenofovirata ni mogoče izključiti (glejte poglavje 5.3).
English: • immunosuppressants used to control your body's immune response after a transplant, containing ciclosporin
Slovenian: • imunosupresive, ki se uporabljajo za nadzor imunskega odziva telesa po presaditvi, kot je ciklosporin
English: Some patients taking combination antiretroviral medicines such as Biktarvy may develop a bone disease called osteonecrosis (death of bone tissue caused by loss of blood supply to the bone).
Slovenian: Pri nekaterih bolnikih, ki jemljejo kombinirana protiretrovirusna zdravila, kot je zdravilo Biktarvy, se lahko pojavi bolezen kosti, imenovana osteonekroza (odmiranje kostnega tkiva kot posledica pomanjkanja oskrbe kosti s krvjo).
English: No interaction is expected with bictegravir and emtricitabine.
Slovenian: Interakcije z biktegravirjem in emtricitabinom se ne pričakujejo.
English: Tenofovir alafenamide and tenofovir have a median plasma half-life of 0.51 and 32.37 hours, respectively.
Slovenian: Alafenamidtenofovirat in tenofovir imata mediani razpolovni čas v plazmi 0,51 oz. 32,37 ur.
English: Co-administration with rifampicin and St. John's wort (Hypericum perforatum) (see section 4.5).
Slovenian: Sočasna uporaba z rifampicinom in šentjanževko (Hypericum perforatum) (glejte poglavje 4.5).
English: Patients co-infected with HIV and HBV who discontinue Biktarvy should be closely monitored with both clinical and laboratory follow-up for at least several months after stopping treatment.
Slovenian: Bolnike s hkratno okužbo s HIV in HBV, ki prekinejo zdravljenje z zdravilom Biktarvy, je potrebno pozorneje opazovati in opravljati potrebne klinične in laboratorijske preiskave še vsaj nekaj mesecev po prenehanju zdravljenja.
English: In patients with moderate renal impairment, close monitoring should be considered when starting co-administration of bictegravir with metformin, due to the increased risk for lactic acidosis in these patients.
Slovenian: Pri bolnikih z zmerno okvaro ledvic je treba razmisliti o natančnem spremljanju ob uvedbi sočasnega dajanja biktegravirja in metformina zaradi povečanega tveganja za laktacidozo pri teh bolnikih.
English: Pharmacokinetics of bictegravir, emtricitabine, and tenofovir have not been fully evaluated in the elderly (≥ 65 years of age).
Slovenian: Farmakokinetike biktegravirja, emtricitabina in tenofovirja pri starejših (≥ 65 let starosti) niso povsem ocenili.
English: In vitro and clinical pharmacokinetic drug-drug interaction studies have shown that the potential for CYP-mediated interactions involving emtricitabine with other medicinal products is low.
Slovenian: Študije in vitro in klinične farmakokinetične študije medsebojnega delovanja zdravil kažejo, da je možnost interakcij, pri katerih posreduje CYP in vključujejo emtricitabin, z drugimi zdravili majhna.
English: Studies in animals with bictegravir have shown no evidence of teratogenicity or an effect on reproductive function.
Slovenian: Študije biktegravirja na živalih niso pokazale dokazov teratogenosti ali vpliva na sposobnost razmnoževanja.
English: • Signs of inflammation or infection • Joint pain, stiffness or bone problems
Slovenian: • znake vnetja ali okužbe • bolečine, togost sklepov ali težave s kostmi
English: 1 This study was conducted using bictegravir 75 mg single dose.
Slovenian: 1 Ta študija je bila izvedena z enkratnim odmerkom biktegravirja 75 mg.